跳至主要内容
临床试验/NCT01224899
NCT01224899已完成1 期

Left Cervico-Thoracic Sympathetic Blockade by Clipping in Systolic Heart Failure: A Randomised Controlled Trial

University of Sao Paulo2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2006年12月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
15
试验地点
2
主要终点
Perioperative mortality and morbidity

研究概览

简要总结

The investigators sought to evaluate the feasibility and safety of surgical sympathetic blockade in systolic heart failure patients and secondary to assess its cardiovascular consequences.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • chronic heart failure (at least 1 month of symptoms onset)
  • NYHA functional class II or III
  • LV ejection fraction 40% or lower
  • resting heart rate higher than 65 bpm
  • either maximum beta-blocker therapy according to guidelines or no beta-blocker use for intolerance.

排除标准

  • NYHA functional class I or IV
  • cardiogenic shock
  • resting heart rate ≤ 65 bpm
  • systolic blood pressure < 90 mmHg
  • sustained ventricular tachycardia
  • eligibility to other surgical procedures
  • procedure-limiting comorbidity
  • presence of ICD or pacemaker
  • valvar, chagasic or congenital cardiomyopathy
  • age > 70 years
  • patient refusal
  • contra-indication to videothoracoscopy
  • decompensated thyroid disease
  • atrial fibrillation or flutter
  • active infection

结局指标

主要结局

Perioperative mortality and morbidity

时间窗: 30 days after operation

Study interruption criteria: * death attributable to surgical procedure; * cardiogenic shock attributable to surgical procedure; * worsening of heart failure symptoms attributable to surgical procedure; * Horner's syndrome * hypotension or bradiarrhythmia attributable to surgical procedure

次要结局

  • Cardiovascular effects(6 months)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验